Design of N-heterocycle based-phthalonitrile/metal phthalocyanine-silver nanoconjugates for cancer therapies

Keyphrases

• Phthalonitrile 100%
• Metallophthalocyanine 100%
• Cancer Therapy 100%
• Silver Nanoconjugates 100%
• N-heterocycles 100%
• Phthalocyanine 75%
• Silver Nanoparticles 75%
• IC50 Value 75%
• Irradiation 50%
• Nanoconjugates 50%
• Ag Nanoparticles (AgNPs) 50%
• UV-VIS Spectroscopy 25%
• Cyclotetramerization 25%
• 1H nuclear Magnetic Resonance (1H NMR) 25%
• Fourier Transform Infrared Spectroscopy (FT-IR) 25%
• Aqueous Media 25%
• Phthalonitrile Derivatives 25%
• Biological Properties 25%
• Ethoxy 25%
• 13C NMR 25%
• Antiproliferative Activity 25%
• Anticancer Agents 25%
• Zn-Co 25%
• Synthesized Compounds 25%
• Carbazole 25%
• Mass Spectroscopy 25%
• Anticancer Properties 25%
• Cytotoxic Activity 25%
• 13C NMR Spectroscopy 25%
• Nanoparticle Surface 25%
• Monosubstituted 25%
• Zn-Mn 25%
• 9H-carbazole 25%
• MTT Assay 25%
• DLD-1 25%
• A549 25%
• Functionalized Silver Nanoparticles 25%
• 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide 25%
• WI-38 25%
• Surficial Modification 25%
• DLD-1 Cell Line 25%
• Substituted Phthalonitriles 25%

Chemistry

• Heterocyclic Compound 100%
• Nanoconjugate 100%
• Phthalocyanine 100%
• Silver Nanoparticle 80%
• IC50 60%
• Fourier Transform Infrared Spectroscopy 20%
• UV/VIS Spectroscopy 20%
• 1H NMR Spectroscopy 20%
• Biological Property 20%
• Antiproliferative 20%
• 13C NMR Spectroscopy 20%
• Mass Spectrometry 20%
• Carbazole 20%
• 9H-Carbazole 20%
• MTT Assay 20%
• 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Phthalocyanine 100%
• Silver Nanoparticle 100%
• Nanoconjugate 100%
• IC50 75%
• Carbazole Derivative 50%
• Carbon 13 25%
• Phthalocyanine Derivative 25%
• 3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide 25%
• Antiproliferative Activity 25%
• Cytotoxicity 25%